Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical Prostatectomy.

[1]  U. Capitanio,et al.  More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. , 2015, European urology.

[2]  R. Phillips.  Bladder cancer: Stem cells repopulate tumours , 2015, Nature Reviews Urology.

[3]  Cesare Cozzarini,et al.  Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  F. Montorsi,et al.  Predicting survival of patients with node-positive prostate cancer following multimodal treatment. , 2014, European urology.

[5]  P. Scardino,et al.  Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. , 2014, European urology.

[6]  Marco Bianchi,et al.  Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. , 2012, European urology.

[7]  Misop Han,et al.  Predicting 15-year prostate cancer specific mortality after radical prostatectomy. , 2011, The Journal of urology.

[8]  E. Bergstralh,et al.  Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. , 2007, The Journal of urology.

[9]  Jorge Yao,et al.  Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. , 2006, The Lancet. Oncology.